Oxidized low-density lipoproteins impair endothelial function by inhibiting non-genomic action of thyroid hormone-mediated nitric oxide production in human endothelial cells

Thyroid

Volumn 23, Issue 2, 2013, Pages 231-238

  Vicinanza, Roberto ^a   Coppotelli, Giuseppe ^a,b   Malacrino, Carolina ^a   Nardo, Tiziana ^a   Buchetti, Barbara ^a   Lenti, Luisa ^a   Celi, Francesco S ^c   Scarpa, Susanna ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4,5 DIAMINOFLUORESCEIN DIACETATE; ALPHA TOCOPHEROL; ASCORBIC ACID; CYCLIC GMP; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE; PROTEIN KINASE B; SERINE; THYROID HORMONE;

ARTICLE; CELL FUNCTION; CELL STIMULATION; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME PHOSPHORYLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; OXIDATION; PRIORITY JOURNAL; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

CYCLIC GMP; ENDOTHELIUM, VASCULAR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LIPOPROTEINS, LDL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; TRIIODOTHYRONINE;

EID: 84873666844     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0524     Document Type: Article

References (41)

1. Cini G, Carpi A, Mechanick J, Cini L, Camici M, Galetta F, Giardino R, Russo MA, Iervasi G 2009 Thyroid hormones and the cardiovascular system: pathophysiology and interventions. Biomed Pharmacother 63:742-753
2. Kahaly GJ, Dillmann WH 2005 Thyroid hormone action in the heart. Endocr Rev 26:704-728
3. Dillmann WH 1996 Thyroid hormone action and cardiac contractility-a complex affair. Endocrinology 137:799-801
4. Pramfalk C, Pedrelli M, Parini P 2011 Role of thyroid receptor b in lipid metabolism. Biochim Biophys Acta 1812: 929-937
5. Klein I, Ojamaa K 2000 The cardiovascular system in hypothyroidism. In: Braverman LE, Utiger RD (eds) Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text, 8th edn. Lippincott Williams & Wilkins Press, Philadelphia, PA, pp 777-782
6. Neves C, Alves M, Medina JL, Delgado JL 2008 Thyroid diseases, dyslipidemia and cardiovascular pathology. Rev Port Cardiol 10:1211-1236
7. Ito M, Arishima T, Kudo T, Nishihara E, Ohye H, Kubota S, Fukata S, Amino N, Kuma K, Sasaki I, Hiraiwa T, Hanafusa T, Takamatsu J, Miyauchi A 2007 Effect of levothyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients. J Clin Endocrinol Metab 92:608-611
8. Ness GC, Zhao Z 1994 Thyroid hormone rapidly induces hepatic LDL receptor mRNA levels in hypophysectomized rats. Arch Biochem Biophys 315:199-202
9. Lopez D, Abisambra Socarrás JF, Bedi M, Ness GC 2007 Activation of the hepatic LDL receptor promoter by thyroid hormone. Biochim Biophys Acta 1771:1216-1225
10. Dagre AG, Lekakis JP, Papaioannou TG, Papamichael CM, Koutras DA, Stamatelopoulos SF, Alevizaki M 2005 Arterial stiffness is increased in subjects with hypothyroidis. Int J Cardiol 103:1-6
11. Klein I, Danzi S 2007 Thyroid disease and the heart. Circulation 116:1725-1735
12. Dillmann WH 2002 Cellular action of thyroid hormone in the heart. Thyroid 12:447-452
13. Diekman MJ, Zandieh Doulabi B, Platvoet-Ter Schiphorst M, Fliers E, Bakker O, Wiersinga WM 2001 The biological relevance of thyroid hormone receptors in immortalized human umbilical vein endothelial cells. J Endocrinol 168: 427-433
14. Hiroi Y, Kim H-H, Ying H, Furuya F, Huang, Z, Simoncini T, Noma K, Ueki K, Nguyen N-H, Scanlan TS, Moskowitz MA, Cheng, SY, Liao JK 2006 Rapid nongenomic actions of thyroid hormone. Proc Natl Acad Sci USA 103:14104-14109
15. Chatterjee A, Black SM, Catravas JD 2008 Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vascul Pharmacol 49:134-140
16. Napoli C, Ignarro LJ 2009 Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch Pharm Res 32:1103-1108
17. Carnevale R, Pignatelli P, Lenti L, Buchetti B, Sanguigni V, Di Santo S, Violi F 2007 LDL are oxidatively modified by platelets via GP91(phox) and accumulate in human monocytes. FASEB J 21:927-934
18. Aust O, Sies H, Stahl W, Polidori MC 2001 Analysis of lipophylic antioxidants in human serum and tissue: tocopherols and carotenoids. J Chromatogr A 936:83-93
19. Puhl H 1994 Methods to determine oxidation of low-density lipoproteins. Methods Enzymol 233:425-441
20. Ortega RM, Requejo AM, Ló pez-Sobaler AM, Andrés P, Navia B, Perea JM, Robles F 2002 Cognitive function in elderly people is influenced by vitamin E status. J Nutr 132:2065-2068
21. Berkels R, Dachs C, Roesen R, Klaus W 2000 Simultaneous measurement of intracellular Ca(2 +) and nitric oxide: a new method. Cell Calcium 27:281-286
22. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ 2003 Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 278:45021-45026
23. Pepine CJ 2009 The impact of nitric oxide in cardiovascular medicine: untapped potential utility. Am J Med 122 Suppl 5:10-15
24. Cardillo C, Panza JA 1998 Impaired endothelial regulation of vascular tone in patients with systemic arterial hypertension. Vasc Med 3:138-144
25. Giardina JB, Tanner DJ, Khalil RA 2001 Oxidized-LDL enhances coronary vasoconstriction by increasing the activity of protein kinase C isoforms alpha and epsilon. Hypertension 37:561-568
26. Galle J, Mameghani A, Bolz SS, Gambaryan S, Gö rg, M, Quaschning T, Raff U, Barth H, Seibold S, Wanner C, Pohl U 2003 Oxidized LDL and its compound lysophosphatidylcholine potentiate AngII-induced vasoconstriction by stimulation of RhoA. J Am Soc Nephrol 14:1471-1479
27. Kamiyama M, Kishimoto Y, Tani M, Utsunomiya K, Kondo K 2009 Effects of equol on oxidized low-density lipoproteininduced apoptosis in endothelial cells. J Atheroscler Thromb 16:239-249
28. Ou HC, Chou FP, Lin TM, Yang CH, Sheu WH 2006 Protective effects of eugenol against oxidized LDL-induced cytotoxicity and adhesion molecule expression in endothelial cells. Food Chem Toxicol 44:1485-1495
29. Augè N, Negre-Salvayre A, Salvayre R, Levade T 2000 Sphingomyelin metabolites in vascular cell signaling and atherogenesis. Prog Lipid Res 39:207-209
30. Leonarduzzi G, Arkan MC, Basaga H, Chiarpotto E, Sevanian A, Poli G 2000 Lipid oxidation products in cell signaling. Free Radic Biol Med 28:1370-1378
31. Napoli C, Quehenberger O, De Nigris F, Abete P, Glass CK, Palinski W 2000 Mildly oxidized LDL activates multiple apoptotic signaling pathways in human coronary cells. FASEB J 14:1996-2007
32. Mazière C, Morlière P, Santus R, Marcheux V, Louandre C, Conte MA, Mazière JC 2004 Inhibition of insulin signaling by oxidized low-density lipoprotein. Protective effect of the antioxidant vitamin E. Atherosclerosis 175:23-30
33. Chavakis E, Dernbach E, Hermann C, Mondorf UF, Zeiher AM, Dimmeler S 2001 Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial cell migration by an inhibitory effect on the Akt/endothelial nitric oxide synthase pathway. Circulation 103:2102-2107
34. Di Santo S, Diehm N, Ortmann J, Völzmann J, Yang Z, Keo HH, Baumgartner I, Kalka C 2008 Oxidized low-density lipoprotein impairs endothelial progenitor cell function by downregulation of E-selectin and integrin alpha(v)beta5. Biochem Biophys Res Commun 373:528-532
35. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D 1984 Modification of low-density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low-density lipoprotein phospholipids. Proc Natl Acad Sci USA 81:3883-3887
36. Henriksen T, Mahoney EM, Steinberg D 1982 Interactions of plasma lipoproteins with endothelial cells. Ann NY Acad Sci 401:102-116
37. Morel DW, Di Corleto PE, Chisolm GM 1984 Endothelial and smooth muscle cells alter low-density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 4:357-364
38. Fang X, Weintraub NL, Rios CD, Chappell DA, Zwacka RM, Engelhardt JF, Oberley LW, Yan T, Heistad DD, Spector AA 1998 Overexpression of human superoxide dismutase inhibits oxidation of low-density lipoprotein by endothelial cells. Circ Res 82:1289-1297
39. Esterbauer H, Dieber-Rotheneder M, Striegl G, Waeg G 1991 Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr 1 Suppl:314-321
40. Saremi A, Arora R 2010 Vitamin E and cardiovascular disease. Am J Ther 17:56-65
41. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, Salvetti A, Ferrannini E, Monzani F 2003 Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 88:3731-3737